In view of the high imminent risk for subsequent fractures, evaluation as early as possible after the fracture will result in early decisions about drug treatment, fall prevention and nutritional supplements. Drug treatment includes anti-resorptive and bone forming agents. Anti-resorptive therapy with broad spectrum fracture prevention and early anti-fracture effects are the first choice. In patients with multiple or severe VFs, the bone forming agent teriparatide should be considered. Adequate calcium and vitamin D are needed in all patients, together with appropriate nutrition, including adequate protein intake.
Geusens, P., Lems, W. F., Bours, S., & vd Bergh, J. P. (2019). Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirements. Best Practice and Research: Clinical Rheumatology, 33(2), 290-300. https://doi.org/10.1016/j.berh.2019.04.005